| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.073 | 0.6 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.088 | 0.6 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.6 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.077 | 0.6 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.6 |